Skip Navigation Links
 Home 
 Registration 
 Pre Registered 
  
 Personal page 
 Archive 
Scroll up
Scroll down
-
-
Scroll up
Scroll down
       XXII Annual Congress of the Iranian Society of Ophthalmology        بـیــست و دومــیــن کنــگــره سـالیـانه انـجـمـن چـشـم پـزشـکی ایـــران
Skip Navigation Links
        صفحه اصلی
        ساختار همایش
        مکان برگزاری
        ثبت نام
        ثبت نام شدگان
         مقالات
        مقالات پذیرفته شده
        ارسال پوستر
        برنامه همایش
        تماس با ما
        صفحه شخصی
        جستجوی سخنران
        آرشیو سمينار سالهای گذشته
 
مقاله Abstract


Title: In-vitro and In-vivo treatment of fungal Keratitis by daily treatment of cold atmospheric pressure plasma jet (CAPPJ)
Author(s): Hamed Nikmaram 1, Maryam Amini 1, Mozhgan Rezaei Kanavi 2, Mahmood Ghoranneviss 1, Sahar Balagholi 2
Presentation Type: Oral
Subject: Cornea
Others:
Presenting Author:
Name: Hamed Nikmaram
Affiliation :(optional) 1-Plasma Physics Research Center,Science and Research Branch of Islamic Azad university,Tehran,Iran. 2-Ocular Tissue Engineering Research Center,Shahid Beheshti University of Medical Sciences,Tehran,Ir
E mail: nikmaram@gmail.com
Phone: 09199350112
Mobile: 09199350112
Purpose:

To investigate in-vitro and in-vivo treatment of fungal keratitis by helium cold atmospheric pressure plasma jet (CAPPJ).

Methods:

Suspensions of Aspergilous fumigatus with 10 6 colony forming units were exposed to CAPPJ 5 minutes daily for 7 days. After culturing the post-treatment suspension in Saboraud agar, fungal colonies were counted. As for in vivo study, fungal keratitis with Aspergilous fumigatus was induced in 3 rabbits and subsequently was treated with CAPPJ 5 minutes daily for 7 days. Size of keratitis was daily evaluated daily and after 7 days microbiologic and histopathologic investigations were performed.

Results:

The results obtained from in vitro treatment of Aspergillus fumigatus proved the efficacy of CAPPJ to inactivate fungal microorganisms. Direct application of the plasma jet in experimental model of fungal keratitis resulted in significant reduction of the size of keratitis; the clinical results were supported by the microbiologic and histopathologic results.

Conclusion:

Both in vitro and in vivo results showed that CAPPJ treatment was effective in inactivating fungal pathogens and therefore it may be considered as a new and safe treatment modality for fungal keratitis.

Attachment:





Last News

  - بـیــست و دومــیــن کنــگــره سـالیـانه انـجـمـن چـشـم پـزشـکی ایـــران